Early mortality in patients with advanced non–small cell lung cancer (aNSCLC) and PD-L1 ≥ 50% receiving first-line immune checkpoint inhibitor (ICI): Analysis of the NOTCH collaborative REAL-SAIF study.
Year: 2026
Type: conference-abstract
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Alfred Chung Pui So, Mary Denholm, Stephen David Robinson, Federico Monaca, Andrew Kidd, Philippa Smith, David Whithey, Mohamed Abdelaziz, Salina Lalwani, Aya Alsayed, Rabia Gul, Daniah Thomas, Alisha Sattar, Samira Bawany, Avinash Aujayeb, Iakov Bolnykh, Kaneez Fathima, Stephanie Eeckelaers, Pablo Martinez Perez, Adam Januszewski
Institutions: St Bartholomew's Hospital, Addenbrooke's Hospital, The Christie NHS Foundation Trust, NHS Greater Glasgow and Clyde, Beatson West of Scotland Cancer Centre, Royal Cornwall Hospital Trust, Royal Cornwall Hospital, University of Manchester, University Hospitals Plymouth NHS Trust, Barts Health NHS Trust, University Hospitals of Leicester NHS Trust, James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, National Health Service Wales, Cambridge University Hospitals NHS Foundation Trust, Maidstone and Tunbridge Wells NHS Trust, Maidstone Hospital, Northumbria Healthcare NHS Foundation Trust, Chelsea and Westminster Hospital NHS Foundation Trust, West Suffolk NHS Foundation Trust, West Suffolk Hospital, Torbay and South Devon NHS Foundation Trust, University Hospitals Sussex NHS Foundation Trust
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162684493
Cites:
Cited by:
Related to: